Vertex Pharmaceuticals Incorporated (BVMF:VRTX34)
Brazil · Delayed Price · Currency is BRL 576.26
+15.80 (2.82%)
At close: Nov 11, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 583.4 billion as of November 13, 2025. Its market cap has decreased by -16.91% in one year.
Market Cap
583.40B
Enterprise Value
529.51B
Revenue
62.48B
Ranking
n/a
PE Ratio
29.79
Stock Price
576.26
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 83.36M to 583.40B, an increase of 699,760.16%. That is a compound annual growth rate of 29.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 583.40B | -9.05% |
| Dec 31, 2024 | 641.42B | 26.08% |
| Dec 29, 2023 | 508.76B | 29.82% |
| Dec 30, 2022 | 391.88B | 25.97% |
| Dec 31, 2021 | 311.09B | -2.53% |
| Dec 31, 2020 | 319.16B | 41.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.14B |
| Raia Drogasil | 39.23B |
| Hypera | 16.31B |
| Fleury | 8.62B |
| Odontoprev | 6.72B |
| Empreendimentos Pague Menos | 2.94B |
| Diagnósticos da América | 2.56B |
| Blau Farmacêutica | 2.26B |